 |
|
Insights and headlines from Shore analysts on trends in enterprise and media content markets.
|
|
|
| Monday, February 25, 2008 |

 I really love Rafael Sidi's Really Simple Sidi weblog, it's a great compilation of insights into sciences publishing that is easy to read and is in my daily bookmarks of news sources to monitor. Turns out that Rafel is a big fan of ContentBlogger also, so I was pleased to get a preview briefing from him on Elsevier's new Illumin8 product making its debut today. While it's hard to draw major conclusions on the significance of any product Day One, it appears that Elsevier has enabled Rafael's team to come up with what promises to be a real breakthrough in STM workflow solutions focused on getting the right insights into emerging solutions to scientific problems effectively. The problem in big-stakes scientific research and development fields is that most search tools are oriented towards topical approaches to research that don't necessarily focus on relating problems and the organizations and people focusing on them with the solutions and benefits that they provide. For example, if one were to look for research, news and Web content relating to the HIV virus, the typical search engine is going to look at a search centered on that term and come up with documents that relate to this topic - but not necessarily focus on the solutions and benefits being provided by specific research studies for available new products. This is a critical factor when trying to select a new line of scientific research or to understand how to position a new product based on that research. How quickly can one define what solutions are in play for specific types of scientific problems by specific companies or universities? Who's delivering the most beneficial solutions? Illumin8 addresses these kinds of questions by adding an important semantic twist to search processing. Instead of focusing just on nouns to define how content relates to a topic Illumin8 clusters results based on how they fall into verb categories that align topic groups such as organizations, products, experts and technology with problems and benefits associated with those topics. Using this tool one can discover easily not just recent research, Web postings and news stories but the items that the real problems being addressed by that research and the real benefits being revealed very rapidly. Illumin8 has a very simple search interface thus far, a "white box" approach that will move from topics to problems and benefits mapping automaticaly or the ability to define more sophisticated queries using special keywords. You can choose from news, research and Web content or any combination of these via a checkbox interface and adjust your precision/recall balance for getting lots of results or just of few of the best matches with a slider bar. Search results come with graph bars and totals to make it easier to see which keywords and clusters of topics, problems and solutions are coming up most frequently in results. While lacking some of the interface sophistication of a more mature product like Collexis that focuses deeply on helping people navigate expert network relationships and still needing to address some entity mapping issues the fundamental power of Illumin8 is quite evident even in its early introduced form. More sophisticated analysis of verbs as valuable tools in semantic processing is in part behind the proliferation of "sales triggers" intelligence products such as Generate and InsideView, which enable sales professionals to understand when news and other content sources are pointing towards companies involved in activities that impact their sales processes. Applying this type of processing to scientific studies and product development is likely to help scientific, medical and technical companies and organizations to get a similar leg up on understanding who's moving towards revenue-impacting insights more quickly. It's an approach that can probably yield tangible benefits for many types of business information as well as consumer information. It would be nice, for example, to see a semantic engine such as Illumin8's applied to product and catalog sites. To some degree many existing search engines factor these kinds of semantic issues into their processing behind the scenes, but Illumin8 demontrates that when one focuses on the problem-solution relationship from a product standpoint instead of a straight topic approach the benefits can be dramatic. I am skeptical oftentimes when new products claim to be "workflow solutions," but Illumin8 seems to be pointing towards a pain point that people in R&D departments encounter often enough without real effective solutions being offered elsewhere that it probably qualifies as such a tool. It's another way of saying that there just might be some significant ROI in there if someone can do the research to tease it out from an early adopter community. Hats off to Rafael for a nifty product launch - helps to have that blog - and to the folks as Elsevier for giving Rafael a chance to strut his stuff. Hopefully Illumin8 continues to grow in scope, substance and quality. Labels: elsevier, rafael sidi, search, Semantic Web, STM
|
|
By John Blossom - posted at 11:20 AM |
permanent link to this entry
bookmark this entry:
|
|
|
|
0 comments (click to view or to add your own)
|
| Tuesday, January 29, 2008 |

 Major book pubishers have not been known in years past for their innovation in adapting to online audiences, but after years of investing modestly in the future of online content many print publishers are stepping up their efforts to capture a new generation of audiences who grew up with online content as a given. Elsevier is one major scientific publisher that seems to have picked up their pace of online innovation significantly as of late, Their announcement last week of 10 major reference works being made available online this year was trumped today by the announcement of a new Wiki-based platform that will enable practicing physicians to update evidence-based medical information online. In both instances Elsevier is betting that some titles will do best as online-only reference materials. Having seen a major response to its making chapters of its Major Reference Works availableonline Elsevier is indicating that two reference titles - the Encyclopedia of Neuroscience and the second edition of Encyclopedia of Ocean Science - are to become online-only references. Elsevier indicates that other reference titles will be available in print for some period of time, but clearly the trend is to move towards online access that's likely to move people into recurring revenues rather than chancing the publication of expensive reference materials. Knovel showed the way years ago to Sci-Tech publishers with its Knovel Library of online reference content, but now the major scientific publishers are beginning to see that electronic additions are going to become the core of their revenues moving forward it's not just a game for aggressive startups. Today's announcement of WiserWiki underscores not only the awareness that Sci-Tech publishers have for the value of online reference but also how best to make use of social media technologies to make it valuable to specific audiences. WiserWiki is seeded with The Textbook of Primary Care Medicine, a reference book covering problems, conditions and diseases encountered in the practices of primary care physicians. No longer in print, what better way to keep this grass-roots information about the real world of medicine than to let the physicians encountering these phenomena to update it themselves? This is a great online product strategy, combining authoritative content from peer professionals as a core that can help to build an online community rapidly. Just as Wikipedia did not spring from thin air - it took more than 100,000 articles from an earlier project to get it going - Wikis built for specialized online communities will work best when there's a core of content to help people feel that they don't have to wait for their contributions to be part of something that has collective merit. Print titles are going to be with us for quite some time to come, but as printing, shipping and stocking expenses fall prey to rising energy and raw materials prices the need for better margins with less risk is pushing book publishers of reference materials inexorably towards "digital native" audiences who have become used to search engines as primary tools for accessing reference content. Obviously other types of titles benefit from this move but for reference works the move is essential if publishers are to keep these products growing and profitable. In the end scientific publishers have much to gain from tranforming their business from one of delivering tomes to delivering content in higly valuable contexts that can drive scientific research and applications forward more rapidly. Labels: books, elsevier, reference, Social Media, STM, Wikis
|
|
By John Blossom - posted at 12:02 PM |
permanent link to this entry
bookmark this entry:
|
|
|
|
0 comments (click to view or to add your own)
|
| Monday, December 03, 2007 |

Rafael Sidi is pumped up about Elsevier's new 2collab social bookmarking service, which he describes as the product of "the young turks in Amsterdam," presumably product developers trying to encourage this major scientific publisher to engage the online world of collaborative content. As what sounds to be a countercultural "intrapreneur" initiative 2collab has a lot going for it. 2collab has all of the features that one would expect to find in a modern social bookmarking service - public and private groups, tagging, commenting, voting, easy bookmarking and a very attractive and highly usable design - combined with editable citation information stored with each bookmark (click on the screen grab above to get a flavor of the metadata). However, the citation data cannot be referenced via the 2collab search engine yet, a minor inconvenience in the short run but something that should be addressed once a significant body of content is aggregated via the service. As to when that significant body will appear is anyone's guess at this point. In spite of a decent launch and prominent billing for the service on Elsevier's corporate portal there appear to be relatively few takers for the service so far. I was challenged to find any publicly posted articles with comments other than my own in five days' worth of posts and thus far today there have been nine public posts in all. To the product's credit the timestamping makes it very easy to figure this out, but in the meantime it's a reminder that the community is still in the process of forming around this product. Group participation doesn't fare much better, with public groups still very small and formed around topics mostly centered on online technology topics. 2collab has an excellent design and the development team is to be commended for a first-rate job in launching a highly credible platform right out of the box, but it's going to take more than features similar to established social media outlets to attract people already using those other platforms. Just as a simple example of the challenge that faces Elsevier, a topic like "congestive heart failure" returns 141 results on del.icio.us, accumulated over a long period of time, to be sure, but in the meantime indicating a ways to go for 2collab to attract active participation. As important as it is to get the technology right in social media it's equally important to get some core communities invested in the platform so that their examples of successful interactions can get other participants jazzed. Consider 2collab to be in serious need of jazzing at this point. Can Elsevier manage to get some more mojo behind 2collab and develop it into a thriving social media community? In truth Elsevier and other scientific publishers are so far behind in embracing social media that it's going to be an uphill struggle for any of them to make significant progress in developing social media capabilities that are, admittedly, rather long-term investments for as-yet-uncertain future revenues. But one thing seems to be certain: whichever scientific publisher is able to finally crack the social media marketplace and develop a tool that becomes the "go-to" place for sharing and discussing scientific literature is going to win a big, big prize at the end of the day - regardless of how that prize scales to current revenue streams. Consider 2collab a modest bet by Elsevier on the future of social media as a publishing platform that is in need of doubling-down sooner rather than later to ensure a place at the emerging world of user-driven publishing markets. Labels: 2collab, collaboration, elsevier, Social Media, STM
|
|
By John Blossom - posted at 2:45 PM |
permanent link to this entry
bookmark this entry:
|
|
|
|
1 comments (click to view or to add your own)
|
| Thursday, October 11, 2007 |

 With much ballyhoo Microsoft unveiled its new HealthVault beta portal recently, a big push by the Microsoft to get a leg up on Google's position as a source for health information. The HealthVault portal itself could hardly be called a portal: it's a landing page that invites you to use a special version of Microsoft's Live Search, set up a portfolio of private health information that can be shared with trusted sources and a link to software that can enable one to download information from health monitoring devices into your HealthVault data. Once you've selected any of these options there's no navigating back to the main portal page. So what you get right now is more of a showcase for potential partners than an online presence that's going to attract an audience. The Live Search tuned up for HealthVault has a number of useful features, many of which have been used for a long time already in Google's health-oriented searches and in Amazon's A9 search portal. The latter similarities are no coincidence, given Amazon's decision a while back to dump Google as a search partner in favor of Microsoft and the highlighting of Amazon's content in the HealthVault portal. Search results are pretty good in HealthVault, with some being downright rich in content and others being merely comparable to Google search results. Put in a broad terms such as "Autism" and HealthVault Live Search returns a column labeled "Articles" with Wikipedia content - kind of a mini- Answers.com - a column of Web search results and a column of sponsored content from Amazon with contextual ads beneath it. Atop this is a category-based navigation similar to Google's Co-Op feature. Something a bit more off the beaten track like "pancreatic cancer ductal tumors" ditches the Wikipedia articles and draws in more scholarly content in search results than one would find in Google, which tends to segregate scholarly resources off in its Google Scholar search. That may or may not be a good thing depending on who is using this feature, but if you're trying to dig deeper into a health issue you definitely have some contrasts between Google and Microsoft to consider. There are also some interesting differences when you try a term that may not be thought of immediately as a health resource, such as "cinnamon," which is now being used as a resource for blood sugar and cholesterol management. In Google there is no health-oriented Co-Op category information available for this search whereas HealthVault provides a very useful taxonomy. However, again HealthVault comes out a little heavy on the hardcore health information and a little light on more consumer-accessible informaiton. If you see an article that interests you in search results you can bookmark it into your HealthVault secure account information via the "Add to Scrapbook" feature, but in doing so you'll have to pass through a login screen and some other screens that were just plain frightening - I had no idea what would happen if I said "yes" to the questions asked, but went along anyway - just to get a bookmark into my HealthVault account. I'll allow that this is a Beta product and that such oddities are likely to be worked out in time, but it's one of those typical instances of Microsoft features that sound great on paper and wind up never working the way that you hoped that they would. The HealthVault Account feature allows a member to use their HealthVault information in association with a number of health screening services and online medical records services, presumably to make it easier for people to give you proper medical care and advice. This is obviously the big corporate hook for HealthVault, with doubtless the hope that major HealthCare providers would default to HealthVault as a common provider of this type of service and enable them in time to deliver streamlined services and benefits based on HealthVault as a common interface. That may very well be, but right out of the box don't expect too many consumers to be jumping head over heels for this service. The non-friendly home page for HealthVault says in essence to the consumer "Hi, we're Microsoft, give us all of your health history details and we'll make it easy for corporations to look at them." Thanks, but I think that we've been there already with Microsoft Wallet, an earlier stab by Microsoft to become the universal online payment service for ecommerce. You'd think that they'd learn from that experience that it helps to look at things from the consumer's perspective first. One of the more promising features of the beta HealthVault is the HealthVault Connection Center, which highlights software that makes it easy for people using health monitoring equipment to collect data from these devices in HealthVault and to make it available to physicians who can scan that information as needed. This plays into Microsoft's strengths as a provider of gizmo interfaces and offers some potential long-term benefits for wellness monitoring services. But even here it's early days for the beta product: the HealthVault Connection Center at this point is just a set of links to Microsoft's device driver and software download pages on the main Microsoft Site. There's no integration to speak of. Microsoft has carved out an ambitious vision for HealthVault, tying in personal, Web and device-driven content into a framework that may make it easier for health care professionals to provide services to patients and wellness enthusiasts. In the still-sketchy outlines of this product you can see how Microsoft sees a huge opportunity to become a master repository for health information that could make it a power player in the health care industry as a result. With the far more competitive and commoditized media marketplace looking less and less like a winner for Microsoft this leveraging of its strengths in both the consumer marketplace and the corporate marketplace may be a great way for Microsoft to firm up its established but threatened footholds in both markets. But clearly this ambitious vision has a long way to go. The Live Seach results are very well designed and promising, but they are not so clearly superior to Google's existing health care offerings that it is likely to create an immediate stampede to Live's view of health information. The corporate feel of the site and the utter lack of deftness in making people feel that there's something in it for them to provide highly sensitive personal information puts a damper on the potentially strong value-add features that could be built off of it. The device integration is a nice concept, but there's a long way to go before we see dashboards built off of this information that will be useful to both consumers and health professionals. There was enough goodness in all of this to get at least one news cycle of positive spin, but there's a long road ahead to make this a viable hit for Microsoft. Still, it's more than its major competitors have done lately to offer a vision of how personal, Web, scholarly and device-driven medical content can come together to improve health care for both consumers and professionals. Microsoft would claim that the've stolen the march from Google with this initiative, and from a vision standpoint they may have a reason to crow a bit. But from an execution standpoint it's a clumsy enough start with typical Microsoft over-hyping of fairly modest features and partner relationships that potential heavyweight content partners are not going to get bowled over immediately as they have been in days past. This may buy Google and others time to come up with their own approaches that may have a more consumer-friendly appeal that will be essential for the long-term success of any such initiative. In the meantime HealthVault's visionary offering gives both content producers and medical professionals a lot to think about in how they plan to make better use of the Web to improve their services to consumers. Labels: collaboration, consumers, enterprise, HealthVault, Microsoft, STM
|
|
By John Blossom - posted at 12:59 PM |
permanent link to this entry
bookmark this entry:
|
|
|
|
1 comments (click to view or to add your own)
|
| Friday, March 02, 2007 |

Information World Review recaps the recently signed declaration of major scientific, technical and medical journal publishers regarding pending E.U. legislation pushing to move towards free and open access to scholarly research after a limited time of private publications. The "Brussels Declaration on STM Publishing" has been gaining signatories over the past few weeks from major publishing houses and academic institutions. The ten-point document is a carefully crafted list of statements that attempts to justify the value of current publishing models to the scholarly community and institutions consuming their research. The statements range from the relatively innocuous - "The mission of publishers is to maximise the dissemination of knowledge through economically self-sustaining business models" - to the provocative: "Open deposit of accepted manuscripts risks destabilising subscription revenues and undermining peer review." In sum the intent of the declaration is to counter the movement towards government-mandated open access to papers deposited in publicly accessible online repositories. There are some compromises in the points designed to whittle away some who may be looking for ways to find some room for compromise - "Raw research data should be made freely available to all researchers" - but in sum the declaration is a statement that says, in effect, that scholarly publishers and the peer review process that supports their publishing processes work just fine and should not be challenged significantly. This is not unexpected, but it is disappointing nevertheless. Scholarly publishers have recognized rightly that their trade is at a major crossroads given the pending E.U. legislation. Pushing forward with government-mandated open access without clear methods to support peer review processes required to generate that research may indeed pose a hazard to the integrity of academic research. But in truth this will be the case regardless of whether the E.U. open access initiative is passed or not. Existing publishing models for scholarly research may be sustainable indefinitely, but the open access movement has created already an important beachhead in the marketplace that questions not just the profit motive but the exiting peer review process. In essence the publishers are saying, "Let's keep our current inefficiencies because this is the only way that we can guarantee monies to sustain peer reviewing of papers." Yet as the demand for print journals diminishes and as more interactive peer review processes unfold through the open access initiative the necessity of high-priced journals pricing to maintain existing peer review methods is likely to be challenged strongly in the open marketplace. Scholarly publishers are so tied to their existing revenue models that they fail to see even greater opportunities for profits in the processes that lead up to final publication. Although access to finalized juried publications is important, it's more important overall to researchers wishing to stay on the edge of important scholarly work to be a part of the discussions and modifications that lead up to the finalization of a paper. The peer review process as it exists today exposes new ideas to too narrow an audience for critique and enhancement prior to final publication. Instead of using today's print-based inefficiencies as the basis for journal pricing publishers should consider developing access to pre-publication materials through community-based online publishing as the basis for premium pricing. This will ensure better input from topic-oriented communities and relieve both publishers and governmental agencies from the need to focus on protecting copyright of finalized materials as the basis for scholarly publishing profits. In an era in which Wikis, weblogs and other social media are demonstrating the ability of community publishing to be monetized effectively content producers of all kinds need to adjust to the idea that controlling copies of content is not as important as managing the communities that generate it and consume it. Copyright still has an important place in publishing but increasingly it will revert to a secondary role as licensing access to private communities whose communications are at least as valuable as finished works of authorship gains center stage. In the marketplace of ideas, people will gravitate towards being in on the key conversations far more than they will the minutes of those conversations. By focusing too intently on the threat to existing monetization models scholarly publishers are likely to be bypassed as other well-funded efforts move past the copyright model and towards more dynamic ways to generate value from scholarly publishing. The Brussels Declaration will to little if anything to change these realities. Labels: Brussels Declaration, copyright, open access, scholarly publishing, Social Media, STM
|
|
By John Blossom - posted at 12:50 PM |
permanent link to this entry
bookmark this entry:
|
|
|
|
0 comments (click to view or to add your own)
|
To top of page  |
|
|
|
 |
|